Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 28 Jan 2026 | Rainer Becker Director | Exchange of views on global pharmaceutical policy developments | SRC |
| 28 Jan 2026 | Agnes Mathieu-Mendes Head of Unit | Exchange of views on global pharmaceutical policy developments | SRC |
| 28 Jan 2026 | Rainer Becker Director | Exchange of views on global pharmaceutical policy developments | — |
| 28 Jan 2026 | Sandra Gallina Director-General | Exchange of views on global pharmaceutical policy developments | — |
| 28 Jan 2026 | Agnes Mathieu-Mendes Head of Unit | Exchange of views on global pharmaceutical policy developments | — |
| 28 Jan 2026 | Sandra Gallina Director-General | Exchange of views on global pharmaceutical policy developments | SRC |
| 02 Oct 2025 | Olivér Várhelyi Commissioner | All pressing portfolio topics | SRC |
| 02 Oct 2025 | Jana Dabbelt Cabinet member | All pressing portfolio topics | SRC |
| 02 Oct 2025 | Jana Dabbelt Cabinet member | All pressing portfolio topics | — |
| 27 Jun 2025 | Rainer Becker Director | Joint meeting SANTE/AEMPS/IQVIA | — |
| 27 Jun 2025 | Rainer Becker Director | Joint meeting SANTE/AEMPS/IQVIA | SRC |
| 26 Feb 2025 | Laszlo Kristoffy Cabinet member | Healthcare, biotech and agri-food policies | — |
| 26 Feb 2025 | Laszlo Kristoffy Cabinet member | Healthcare, biotech and agri-food policies | SRC |
Mission & Goals
IQVIA is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry dedicated to creating intelligent connections that deliver unique innovations and actionable insights.
EU Legislative Interests
Implementation of the Regulation for European Health Data Space Ongoing revision of the General Data Protection Regulation Implementation of the Regulation laying down harmonised rules on Artificial Intelligence (Artificial Intelligence Act) European Health Initiative Implementation of the Regulation on Health Technology Assessment Implementation of the updated general pharmaceutical legislation (published Feb 2026) Ongoing discussion around medicines shortages (Critical Medicines Alliance and proposed Critical Medicines Act) - now in trilogue EU Life Science Strategy EU plan for cardiovascular health - under implementation Proposal from EC in Dec 2025 on a Biotech Act - now being reviewed by EP and Parliament Following proposal for 28 Regime as part of competitiveness agenda Ongoing discussion on AMR (antimicrobial resistance): incentives for development of new antibiotics; securing supplies/continuation of existing antibiotics; and bring back to the market older antibiotics that have been discontinued Implementation of the Urban Wastewater Directive (currently under legal challenge) Convention on Biological Diversity: access and benefit sharing for digital sequence information Following MFF process with focus on future Horizon programs, incl IHI
Communication Activities
Several reports have been published by the IQVIA Institute that are relevant to the EU policy debate on pharmaceutical policies: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports IQVIA has participated in many stakeholder events, particularly in Brussels. IQVIA meets regularly to share and insights with several DGs (SANTE, HERA, GROW, RTD, COMP) and with trade associations in Brussels (EFPIA, Medicines for Europe, Affordable Medicines Europe, EuropaBio, EUCOPE, GIRP, AESGP, as well as with payer association ESIP/MEDEV, and with civil society / NGOs such as EPF, BEUC and Eurordis.
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
Digital Health Society (https://thedigitalhealthsociety.com) Global Health Connector (https://echalliance.com) Partners in Research for IHI: https://www.ihi.europa.eu) Association of Clinical Research Organisations (www.acrohealth.org)
Organisation Members
Part of the IQVIA group (www.iqvia.com) with subsidiaries and partner companies in all EU member states